Hydroxychloroquine sulfate (Cadila Healthcare Limited)
Welcome to the PulseAid listing for the Hydroxychloroquine sulfate drug offered from Cadila Healthcare Limited. This Antirheumatic Agent [EPC],Antimalarial [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Cadila Healthcare Limited |
| NON-PROPRIETARY NAME: | Hydroxychloroquine sulfate |
| SUBSTANCE NAME: | HYDROXYCHLOROQUINE SULFATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Antirheumatic Agent [EPC],Antimalarial [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2008-01-03 |
| END MARKETING DATE: | 0000-00-00 |
Hydroxychloroquine sulfate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Hydroxychloroquine sulfate from Cadila Healthcare Limited |
| LABELER NAME: | Cadila Healthcare Limited |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200(mg/1) |
| START MARKETING DATE: | 2008-01-03 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 65841-633_b356ba48-4115-49ab-93e7-26a45eca9175 |
| PRODUCT NDC: | 65841-633 |
| APPLICATION NUMBER: | ANDA040657 |
Other HYDROXYCHLOROQUINE SULFATE Pharmaceutical Manufacturers / Labelers:
